Chondropathies

RSIP Vision Announces New Tool for Sports Medicine Applications, Enabling Automated Assessment of Cartilage Damage

Retrieved on: 
Monday, July 12, 2021
Medical devices, Health, Technology, Surgery, Software, Biotechnology, Medical specialties, Clinical medicine, Chondropathies, Osteochondritis dissecans, Cartilage, Articular cartilage damage, Medicine, Realm-Specific IP, Image segmentation

This new software module enables quick, precise, deep learning-based segmentation of joint cartilage from MRI scans of hips, knees, and ankles.

Key Points: 
  • This new software module enables quick, precise, deep learning-based segmentation of joint cartilage from MRI scans of hips, knees, and ankles.
  • View the full release here: https://www.businesswire.com/news/home/20210712005244/en/
    3D model of RSIP Vision's cartilage segmentation tool for sports medicine applications (Graphic: Business Wire)
    Chondral lesions are particularly prevalent among young and active patients, including athletes.
  • RSIP Vision has extensive experience and expertise in MRI segmentation of soft tissues, offering fully automated segmentations with submillimeter accuracy.
  • RSIP Visions new module is essential in sports medicine, where cartilage damage is a common and debilitating problem among athletes from all fields.

Relapsing Polychondritis Foundation to Present Poster Highlighting Establishment of Penn RP Program at the EULAR 2021 Virtual Congress

Retrieved on: 
Wednesday, May 26, 2021
Medical specialties, Medicine, Rheumatology, Clinical medicine, Chondropathies, Connective tissue diseases, Relapsing polychondritis, Chondritis, European League Against Rheumatism, Cision, Rheumatism, Poster session

NEW YORK, May 26, 2021 /PRNewswire-PRWeb/ -- The Relapsing Polychondritis Foundation announced that a poster abstract about the founding and launch of the Penn RP Program (Philadelphia, PA) has been accepted for presentation by the European Alliance of Associations for Rheumatology (EULAR) 2021 Virtual Congress to be held on June 2-5, 2021, in Paris, France.

Key Points: 
  • NEW YORK, May 26, 2021 /PRNewswire-PRWeb/ -- The Relapsing Polychondritis Foundation announced that a poster abstract about the founding and launch of the Penn RP Program (Philadelphia, PA) has been accepted for presentation by the European Alliance of Associations for Rheumatology (EULAR) 2021 Virtual Congress to be held on June 2-5, 2021, in Paris, France.
  • "We are excited and honored to participate in the EULAR 2021 Virtual Congress and share how a patient's work in advocacy helped build a powerhouse research program.
  • Details of the abstract and poster presentation are as follows:
    Date: Available for browsing on June 3, 2021 through July 5, 2021.
  • For more information about relapsing polychondritis, the RP Foundation, and the Race for RP, please visit https://www.polychondritis.org and https://raceforrp.org/ .

Insights on the Knee Cartilage Repair Global Market to 2027 - Featuring Osiris Therapeutics, Stryker & TiGenix Among Others - ResearchAndMarkets.com

Retrieved on: 
Monday, December 21, 2020
Surgery, Health, Chondropathies, Osteochondritis dissecans, Cartilage, Organ transplantation, Clinical medicine, Medicine, Health

The "Knee Cartilage Repair - Global Market Trajectory & Analytics" report has been added to ResearchAndMarkets.com's offering.

Key Points: 
  • The "Knee Cartilage Repair - Global Market Trajectory & Analytics" report has been added to ResearchAndMarkets.com's offering.
  • The 194-page report presents concise insights into how the pandemic has impacted production and the buy side for 2020 and 2021.
  • The U.S. Market is Estimated at $952.1 Million, While China is Forecast to Grow at 7.5% CAGR
    The Knee Cartilage Repair market in the U.S. is estimated at US$952.1 Million in the year 2020.
  • In the global Osteochondral Grafts Transplantation segment, USA, Canada, Japan, China and Europe will drive the 4% CAGR estimated for this segment.

Relapsing Polychondritis Patients and Advocates Emphasize the Benefits of Collaboration in Prestigious Patient Perspective Poster Program

Retrieved on: 
Tuesday, December 8, 2020
Medical specialties, Clinical medicine, Autoimmune diseases, Chondropathies, Connective tissue diseases, Rheumatology, Medicine, Relapsing polychondritis, Chondritis, Poster session

This year's annual meeting also featured five relapsing polychondritis patient poster submissions that were selected for presentation.

Key Points: 
  • This year's annual meeting also featured five relapsing polychondritis patient poster submissions that were selected for presentation.
  • Four of the posters were sponsored by the Relapsing Polychondritis Foundation and one poster was sponsored by the Canadian Society for Relapsing Polychondritis .
  • "Poster presentations like these are an important part of our efforts," said David Bammert, President of the RP Foundation.
  • "They provide the opportunity for the medical community to better understand the patient's perspective regarding living with RP and facilitate pathways for more efficient patient care."

J. Lee Pace, MD, FAAOS, is being recognized by Continental Who's Who

Retrieved on: 
Thursday, August 27, 2020
Chondropathies, Medical specialties, Clinical medicine, Medicine, Osteochondritis dissecans, Orthopedic surgery, Osteochondritis

Highly distinguished, board-certified Orthopedic Surgeon Dr. Pace has led an impressive career having accrued 15 years of professional excellence in his respected field.

Key Points: 
  • Highly distinguished, board-certified Orthopedic Surgeon Dr. Pace has led an impressive career having accrued 15 years of professional excellence in his respected field.
  • He has gained valuable extensive training and experience, throughout his career, specializing in sports medicine surgeries in children and adults.
  • In addition, he has developed and continues to improve a procedure called retro-articular core decompression to correct osteochondritis dissecans of the knee.
  • Dr. Pace dedicates this recognition to his organic chemistry teacher, Ty Redd, Ph.D., and his orthopedic surgery mentors Drs.

Cell Therapy Tools for Cartilage Repair From Osteoarthritic Knee Joint of Elderly

Retrieved on: 
Thursday, June 18, 2020
Research, Surgery, Seniors, Fitness & Nutrition, Biotechnology, Other Health, Health, Consumer, Science, Medical specialties, Musculoskeletal system, Medicine, Arthritis, Chondropathies, Cartilage, Connective tissue, Skeletal system, Osteochondritis dissecans, Knee, Arthroplasty, Chondrogenesis

OA affects, knee joints of millions globally and those with severe disease, undergo Total Knee Arthroplasty (TKA), in which damaged cartilage is replaced with artificial knee prosthesis.

Key Points: 
  • OA affects, knee joints of millions globally and those with severe disease, undergo Total Knee Arthroplasty (TKA), in which damaged cartilage is replaced with artificial knee prosthesis.
  • (Photo: Business Wire)
    Cartilage of the knee joint acts as a cushion between bones of the thigh and leg and absorbs the body weight.
  • When cartilage is damaged due to sports injury, trauma or wear and tear, it causes joint pain and disability.
  • "Our technique may help utilize OA affected cartilage, discarded as biomedical waste, as a source of tools of cell therapies viz., cells, cell secreted growth factors, and exosomes to repair cartilage defects in regenerative medicine," he added.

Relapsing Polychondritis Foundation Announces a Powerhouse Healthcare Coalition

Retrieved on: 
Tuesday, May 26, 2020
Medical specialties, Medicine, Chondropathies, Organ systems, Connective tissue diseases, Rheumatology, Autoimmune diseases, Relapsing polychondritis, Chondritis, Cartilage

With support from Race for RP, Nancy Linn and Neil Langberg, the Penn Relapsing Polychondritis Fund will expand these exceptional programs that will improve care for patients with RP.

Key Points: 
  • With support from Race for RP, Nancy Linn and Neil Langberg, the Penn Relapsing Polychondritis Fund will expand these exceptional programs that will improve care for patients with RP.
  • "As a patient, I am extremely pleased the Foundation has implemented its plan to support research to advance a cure for relapsing polychondritis," said Nancy Linn, Chair of the Relapsing Polychondritis Foundation.
  • "The Penn RP Program represents the RP Foundation's unwavering commitment to powerful research initiatives that improve patient care and relentlessly advance the path to a cure," said David Bammert, President of the Relapsing Polychondritis Foundation.
  • Relapsing polychondritis (RP) is a debilitating and sometimes fatal systemic inflammatory disease characterized by recurrent inflammation of cartilage and other tissues throughout the body.

Histogen Publishes New Preclinical Data on its HST 003 Orthopedic Program

Retrieved on: 
Wednesday, April 15, 2020
Skeletal system, Connective tissue, Medicine, Chondropathies, Osteochondritis dissecans, Cartilage, Branches of biology, Clinical medicine, Hyaline cartilage

We have now tested HST 003 in three animal models, and the results have been consistent and exciting, said Dr. Gail Naughton, Founder and Chief Science Officer of Histogen.

Key Points: 
  • We have now tested HST 003 in three animal models, and the results have been consistent and exciting, said Dr. Gail Naughton, Founder and Chief Science Officer of Histogen.
  • In vivo preclinical studies showed that treating full thickness osteochondral lesions with HST 003 resulted in hyaline cartilage and mature bone formation in rats (ODriscoll score p
  • The results seen in these latest preclinical studies support the advancement of our key HST 003 program, said Richard Pascoe, Chairman and CEO of Histogen.
  • Approximately 18 million U.S. patients suffer from knee osteoarthritis, a debilitating degenerative disease characterized by softening and disintegration of cartilage.

Global Cartilage Repair and Regeneration Market, by Treatment Modalities (Cell-Based Approach, Non-Cell-Based Approach), by Procedure Type, by Application Outlook 2022

Retrieved on: 
Tuesday, March 31, 2020
Medical specialties, Medicine, Clinical medicine, Connective tissue, Skeletal system, Chondropathies, Osteochondritis dissecans, Cartilage, Regeneration, Articular cartilage repair, Autologous matrix-induced chondrogenesis

According to this new release, "Global Cartilage Repair and Regeneration Market, by Treatment Modalities (Cell-Based Approach, Non-Cell-Based Approach), by Procedure Type, by Application Outlook 2022 ", the industry is expanding at a fast pace.

Key Points: 
  • According to this new release, "Global Cartilage Repair and Regeneration Market, by Treatment Modalities (Cell-Based Approach, Non-Cell-Based Approach), by Procedure Type, by Application Outlook 2022 ", the industry is expanding at a fast pace.
  • As per the report, the Cartilage Repair and Regeneration market is anticipated to witness a high double digit growth during the forecasted period (2016-2022).
  • This report provides a detailed analysis of the current and future market scenario of the global Cartilage Repair and Regeneration market.
  • In terms of procedure type, microfracture and ACI are the most common procedure observed amongst all the types of cartilage repair procedure.

Race for Relapsing Polychondritis' Drive for Awareness Makes a Stop in Marquette this Week for A Symposium Exploring Autoimmune Diseases

Retrieved on: 
Wednesday, September 18, 2019
Medical specialties, Medicine, Health, Autoimmune diseases, Connective tissue diseases, Rheumatology, RTT, Chondropathies, Relapsing polychondritis, Chondritis, Rheumatism, Autoimmunity

Whether it's lupus, rheumatoid arthritis, relapsing polychondritis or one of the many other autoimmune diseases, not nearly enough is known about diagnosis and treatment.

Key Points: 
  • Whether it's lupus, rheumatoid arthritis, relapsing polychondritis or one of the many other autoimmune diseases, not nearly enough is known about diagnosis and treatment.
  • NMU's Doctor of Nursing Practice Program, in conjunction with the Race for RP (Relapsing Polychondritis) present A Symposium Exploring Autoimmune Diseases, Friday, September 20, at Reynolds Recital Hall.
  • A Symposium Exploring Autoimmune Diseases takes place Friday, September 20, 12:30 p.m. 4:00 p.m. at Reynolds Recital Hall at NMU.
  • For additional information visit, http://www.bit.ly/AutoimmunitySymposium
    Race for RP supports research, awareness programs, and quality care for those who are affected by relapsing polychondritis and related diseases.